Skip to content

Clinical trials

Phase 2 Blast Crisis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blast Crisis Phase: Phase 2 Clear all

116 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
20018
20025
20035
20048
20059
200612
20079
20082
20094
20102
20114
20121
20131
20143
20151
20171
20182
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Terminated17
Unknown status5
Withdrawn5
Recruiting3
Active, not recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center23
M.D. Anderson Cancer Center9
Case Comprehensive Cancer Center7
Memorial Sloan Kettering Cancer Center7
National Cancer Institute (NCI)6
H. Lee Moffitt Cancer Center and Research Institute4
Roswell Park Cancer Institute4
City of Hope Medical Center3
Masonic Cancer Center, University of Minnesota3
Northside Hospital, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blast Crisis116
Leukemia, Myeloid, Accelerated Phase79
Precursor Cell Lymphoblastic Leukemia-Lymphoma76
Leukemia, Myeloid, Acute75
Leukemia72
Leukemia, Myeloid, Chronic-Phase61
Myelodysplastic Syndromes56
Leukemia, Lymphocytic, Chronic, B-Cell55
Burkitt Lymphoma54
Lymphoma, Follicular49

Trials

Showing 76 to 100 of 116. Each trial links to its page on Pharma Observatory.

16 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.